MondayFeb 12, 2018 4:12 pm

AV1 Group, Inc. (AVOP) Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

Jon Fortune joins AV1 as strategic corporate advisor LED lighting is cost- and energy-efficient for companies, homes and grow houses X-Fire Smart Systems™ is an innovative solution for smart cities and homes AV1 Group, Inc. (OTC: AVOP) recently announced the addition of Jon Fortune to its team. In a news release, AV1 Group CEO Bryen Beglinger stated, “We welcome Jon to our team. He has a wealth of experience and with his expertise in renewable energy, he will be a significant asset. He has a number of contacts in the industry that he is already working with on co-development opportunities,…

Continue Reading

MondayFeb 12, 2018 1:30 pm

ChineseInvestors.com, Inc. (CIIX) Reaching Chinese-Speaking Audience through Video Broadcasts and New Mobile App

CIIX diversifies methods of reaching its global Chinese-speaking audience, with projects ranging from a daily video broadcast from the NYSE on cryptocurrencies to the development of a new social media mobile app for the cannabis industry Company’s new mobile app expected to be the first Chinese-language app offering reviews and discussion of cannabis products ‘Bitcoin MultiMillionaire’ is the company’s daily video broadcast from the NYSE prepared for its unique and expansive audience ChineseInvestors.com, Inc. (OTCQB: CIIX) is reaching out to the global Chinese-speaking community through both daily video broadcasts on cryptocurrencies and, soon, a new mobile app focused on reviews…

Continue Reading

MondayFeb 12, 2018 12:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expanding Best-in-Class Product Line

Lexaria has developed an oral digestion technology that may translate into lower dosages and shorter treatment regimens Company is expanding its edible product offerings through a licensing agreement with a Canadian cannabis chocolate manufacturer Lexaria continues to develop products for demonstration, testing and sales Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed DehydraTECH™, an oral digestion technology believed to improve the absorption rates of nicotine, non-steroid anti-inflammatory drugs (NSAIDs), vitamins and cannabinoids by as much as five to ten times the normal rate. The time of onset is also reduced, and effects are felt within 15 to 20 minutes…

Continue Reading

MondayFeb 12, 2018 11:24 am

QualityStocksNewsBreaks – MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) Announces Refinement of Lithium Extraction Process

Diversified resource and technology company MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) this morning announced that the adsorption rate of its lithium extraction nanofiltration process has been increased from 20mg/g (milligram of lithium per gram of adsorption reagent) to an optimized rate of 40mg/g. Per the update, this reflects a significant cost-cutting breakthrough, as reagents account for the single largest cost in the company’s lithium extraction process. In addition to reducing reagent use and the direct cost of lithium chloride recovery from brine, reagent depletion in the lithium nanofilter has now been reduced to less than one percent…

Continue Reading

MondayFeb 12, 2018 10:22 am

QualityStocksNewsBreaks – PotNetwork Holding, Inc. (POTN) Releases Unaudited Financial Statements for FY2017

PotNetwork Holding, Inc. (OTC: POTN) this morning announced the release of its unaudited financial statements for fiscal year 2017. Owing to the rapid growth of its wholly-owned Diamond CBD, Inc. subsidiary, PotNetwork achieved revenues of $14.5 million in calendar 2017. Per the update, this trend of strong sales has continued into 2018, and the company intends to report its January sales figures by mid-February. PotNetwork also provided an update regarding its ongoing PCAOB audit in this morning’s news release. Due to factors beyond the company’s control, the audit has taken longer than originally projected. In an effort to combat these…

Continue Reading

FridayFeb 09, 2018 3:49 pm

Teewinot Life Sciences Corporation is Producing Cannabinoids without Touching the Plant

Producing cannabinoids through biosynthesis CANNSYNTHESIS® platform has capacity to scale up Revenues from out-licensing technology For the half a billion or so who suffer from one type or another of diabetes, biosynthesis offers a lifeline. For it is through biosynthesis that much of the world’s insulin is produced. Insulin regulates the metamorphosis of fats and protein and, importantly, allows the cells in the muscles, fat and liver to absorb glucose from the blood. When the body does not produce enough insulin nor use the insulin it produces efficiently, blood sugar levels may rise dangerously. However, biosynthesis, a mid-twentieth century technology,…

Continue Reading

FridayFeb 09, 2018 2:52 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Skinvisible, Inc. (OTCQB: SKVI) is working toward developing a transdermal treatment for post-traumatic stress disorder through its patented Invisicare® technology that could address the devastating number of veteran suicides that occur throughout the country. The company’s proposed merger with Quoin Pharmaceuticals would direct Skinvisible’s drug delivery capacity to boost the bioavailability of Quoin’s promising pharmaceuticals. An article discussing this reads: “Skinvisible, through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., has already developed, licensed and sold multiple dermatology and health care products, as well as various medical treatments, using its patented Invisicare® technology. … Quoin’s two lead products are targeting crises…

Continue Reading

FridayFeb 09, 2018 12:52 pm

QualityStocksNewsBreaks – PotNetwork Holding Inc. (POTN) Sales Drive Optimistic Share Price Target

PotNetwork Holding Inc. (OTC: POTN) has reported favorable monthly sales data and a strong quarterly filing in its drive to produce high-grade CBD for use in oils, tinctures, edibles and vape liquids. This performance is, in turn, generating forecasts for a heightened share price. The holding company for a number of subsidiaries in the hemp-extract medical cannabis industry, PotNetwork has been named 'One of Five Notable CBD Revolution Industry Leaders' by media outlet The Huffington Post. An article discussing this reads: "A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a…

Continue Reading

FridayFeb 09, 2018 10:40 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. Secures Financing Boost for Cannabis Facilities Expansion

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, has benefited from strategic investments by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) and other private placement financing, with its total financing climbing to $160 million. The Aurora investment in TGOD is accompanied by a supply agreement providing Aurora the right to purchase up to 20 percent of TGOD’s annual production of organic cannabis, and TGOD will receive additional services from Aurora and its subsidiary, Aurora Larssen Projects Inc. ("ALPS"). An article discussing this reads: “The investment fully funds the expansion of…

Continue Reading

FridayFeb 09, 2018 10:22 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advancing Work on Novel Delivery for Cannabinoid Therapies

A partnership between health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Australia’s UniQuest Pty Limited aimed at furthering research and development of a soluble gel is working toward a novel means of delivering cannabinoids to the central nervous system directly from the nasal cavity in order to treat pain, inflammation, seizures and neurological disorders. The partnership is taking advantage of the growing legalization of medical marijuana throughout the world amid increasing evidence of cannabinoids’ benefits. An article discussing this reads: “The global nasal drug delivery technology market is projected to reach $64 billion by 2021,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered